Examples of Company Pharmaceutical Products in a sentence
All current and former officers and employees of the Company who are or have been involved in the creation or development of Company Intellectual Property material to the manufacture, use, sale, offer for sale or importation of any Company Pharmaceutical Products have executed and delivered to the Company an agreement providing for the protection of proprietary information and the assignment to the Company of such Intellectual Property.
No Governmental Body has at any time from January 1, 2000 challenged in writing the right of any of the Acquired Corporations to develop, manufacture, offer or sell any of the Company Pharmaceutical Products.
All current and former consultants and independent contractors to the Company who are or have been involved in the creation or development of Company Intellectual Property material to the manufacture, use, sale, offer for sale or importation of any Company Pharmaceutical Products have executed and delivered to the Company an agreement providing for the protection of proprietary information and the assignment to the Company of such Intellectual Property.
Section 4.1(p)(i)(B) of the Company Disclosure Schedule lists all Patents relating to any Company Pharmaceutical Products that are jointly owned by the Company or its Subsidiary.
Except for compassionate use, the Company does not sell and has never sold any Company Pharmaceutical Products.
Besides, the instruments were compared at a high level without taking their intrinsic properties into account.
The Company has not received any written notice that the FDA or any other governmental entity has commenced, or threatened to initiate, any action to withdraw approval, place marketing or sale restrictions, or request the recall of any Company Pharmaceutical Product, or commenced, or threatened to initiate, any action to enjoin or place restrictions on the production, sale, marketing or reimbursement of any Company Pharmaceutical Products.
Section 4.1(p)(i)(A) of the Company Disclosure Schedule lists all (x) Patents relating to any Company Pharmaceutical Products that are owned solely by the Company or its Subsidiary and (y) Trademarks that are the subject of a registration or a pending application for registration and material unregistered Trademarks, in each case, owned by the Company or its Subsidiary.
To the Company's knowledge, all biological and drug products being manufactured, distributed, or developed by the Company ("Company Pharmaceutical Products") that are subject to the jurisdiction of the FDA are being manufactured, labeled, stored, tested, distributed, and marketed in compliance with all applicable requirements under the FDCA and the Public Health Service Act, and their applicable implementing regulations.
The Company has not received any notice or any other form of communication from any Person regarding any actual or possible violation of, or failure to comply with, any Legal Requirement applicable to the manufacture, use, sale or investigation of any Company Pharmaceutical Products, including any FDA Form 483, Warning Letter or any other adverse action or notice from the FDA or other applicable Regulatory Authorities.